About Dual specificity protein phosphatase 1
Dual specificity protein phosphatase 1 (DUSP1) is a protein
from Homo sapiens identified by UniProt accession
P28562, 367 residues long.
MolForge cross-references it against 0 known binders and
392 disease associations.
Target properties
| Protein name | Dual specificity protein phosphatase 1 |
| UniProt accession | P28562 |
| Gene | DUSP1 |
| Organism | Homo sapiens |
| Length | 367 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (392)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.45
- mean corpuscular volume · score 0.43
- C-reactive protein measurement · score 0.41
- Red cell distribution width · score 0.39
- diastolic blood pressure · score 0.35
- mean corpuscular hemoglobin · score 0.35
- cup-to-disc ratio measurement · score 0.33
- birth weight · score 0.33
- mean corpuscular hemoglobin concentration · score 0.32
- pancreatic adenocarcinoma · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P28562-F1 | alphafold | PREDICTED | 79.17 | — |
Amino-acid sequence (367 residues)
MVMEVGTLDA GGLRALLGER AAQCLLLDCR SFFAFNAGHI AGSVNVRFST IVRRRAKGAM GLEHIVPNAE LRGRLLAGAY HAVVLLDERS AALDGAKRDG TLALAAGALC REARAAQVFF LKGGYEAFSA SCPELCSKQS TPMGLSLPLS TSVPDSAESG CSSCSTPLYD QGGPVEILPF LYLGSAYHAS RKDMLDALGI TALINVSANC PNHFEGHYQY KSIPVEDNHK ADISSWFNEA IDFIDSIKNA GGRVFVHCQA GISRSATICL AYLMRTNRVK LDEAFEFVKQ RRSIISPNFS FMGQLLQFES QVLAPHCSAE AGSPAMAVLD RGTSTTTVFN FPVSIPVHST NSALSYLQSP ITTSPSC
Explore Dual specificity protein phosphatase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets